Lance Stapleton is an experienced scientist with a robust background in biological research and immunology. Currently serving as a Senior Associate Scientist at Gilead Sciences since March 2016, Lance previously held roles at Compugen Inc. and Novartis, focusing on immuno-oncology and biological therapeutics, respectively. Notable contributions include decision-driving research on biological markers for antibody-based therapeutics and optimization of validation protocols. Earlier experience at UCSF involved NIH-funded research on small molecule inhibitors targeting cancer growth, while initial work as a Laboratory Technician at Davis Sequencing LLC involved high-throughput PCR processing. Lance holds a Master of Science in Biology from the University of San Francisco and a Bachelor of Science in Genetics from the University of California, Davis.
This person is not in the org chart
This person is not in any offices